TY - JOUR
T1 - Involvement of Resveratrol against Brain Cancer
T2 - A Combination Strategy with a Pharmaceutical Approach
AU - Karthika, Chenmala
AU - Najda, Agnieszka
AU - Klepacka, Joanna
AU - Zehravi, Mehrukh
AU - Akter, Rokeya
AU - Akhtar, Muhammad Furqan
AU - Saleem, Ammara
AU - Al-Shaeri, Majed
AU - Mondal, Banani
AU - Ashraf, Ghulam Md
AU - Tagde, Priti
AU - Ramproshad, Sarker
AU - Ahmad, Zubair
AU - Khan, Farhat S.
AU - Rahman, Md Habibur
N1 - Publisher Copyright:
© 2022 by the authors.
PY - 2022/7
Y1 - 2022/7
N2 - A brain tumor (BT) is a condition in which there is growth or uncontrolled development of the brain cells, which usually goes unrecognized or is diagnosed at the later stages. Since the mechanism behind BT is not clear, and the various physiological conditions are difficult to diagnose, the success rate of BT is not very high. This is the central issue faced during drug development and clinical trials with almost all types of neurodegenerative disorders. In the first part of this review, we focus on the concept of brain tumors, their barriers, and the types of delivery possible to target the brain cells. Although various treatment methods are available, they all have side effects or toxic effects. Hence, in the second part, a correlation was made between the use of resveratrol, a potent antioxidant, and its advantages for brain diseases. The relationship between brain disease and the blood–brain barrier, multi-drug resistance, and the use of nanomedicine for treating brain disorders is also mentioned. In short, a hypothetical concept is given with a background investigation into the use of combination therapy with resveratrol as an active ingredient, the possible drug delivery, and its formulation-based approach.
AB - A brain tumor (BT) is a condition in which there is growth or uncontrolled development of the brain cells, which usually goes unrecognized or is diagnosed at the later stages. Since the mechanism behind BT is not clear, and the various physiological conditions are difficult to diagnose, the success rate of BT is not very high. This is the central issue faced during drug development and clinical trials with almost all types of neurodegenerative disorders. In the first part of this review, we focus on the concept of brain tumors, their barriers, and the types of delivery possible to target the brain cells. Although various treatment methods are available, they all have side effects or toxic effects. Hence, in the second part, a correlation was made between the use of resveratrol, a potent antioxidant, and its advantages for brain diseases. The relationship between brain disease and the blood–brain barrier, multi-drug resistance, and the use of nanomedicine for treating brain disorders is also mentioned. In short, a hypothetical concept is given with a background investigation into the use of combination therapy with resveratrol as an active ingredient, the possible drug delivery, and its formulation-based approach.
KW - antioxidants
KW - blood–brain barrier
KW - brain tumor
KW - nasal delivery
KW - P-glycoprotein
KW - resveratrol
UR - http://www.scopus.com/inward/record.url?scp=85135135311&partnerID=8YFLogxK
U2 - 10.3390/molecules27144663
DO - 10.3390/molecules27144663
M3 - Review article
C2 - 35889532
AN - SCOPUS:85135135311
VL - 27
JO - Molecules
JF - Molecules
IS - 14
M1 - 4663
ER -